XTRA:BAYNPharmaceuticals
Bayer (XTRA:BAYN) Valuation Check After Strong 1 Year Shareholder Return
How Bayer’s Recent Performance Frames the Investment Debate
Bayer (XTRA:BAYN) has attracted fresh attention after a strong share price move, with the stock showing a 20% gain over the past month and a very large 104% total return over the past year.
See our latest analysis for Bayer.
That 20.4% 30 day share price return comes on top of a 54.8% 90 day gain and a 104.4% 1 year total shareholder return, which together point to strong recent momentum, even after weaker 3 and 5 year total...